A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Clinical trial NCT03804125 · WITHDRAWN

Trial details

NCT number: NCT03804125
Sponsor: Pfizer
Status: WITHDRAWN
Study type: OBSERVATIONAL

Cerebral Stroke Thrombosis, Deep Vein Pulmonary Embolism

Start date: 2021-09-01
Primary completion: 2023-06-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.